232 related articles for article (PubMed ID: 28572268)
41. New psychoactive substances in oral fluid of French and Belgian drivers in 2016.
Richeval C; Wille SMR; Nachon-Phanithavong M; Samyn N; Allorge D; Gaulier JM
Int J Drug Policy; 2018 Jul; 57():1-3. PubMed ID: 29631107
[TBL] [Abstract][Full Text] [Related]
42. Hair drug testing in the new Brazilian regulation to obtain professional driver's licence: no parallel to any other law enforcement in the world.
Leyton V; Andreuccetti G; de Almeida RM; Muñoz DR; Walls HC; Greve JM; da Costa Montal JH; Adura FE; Yonamine M
Addiction; 2015 Jul; 110(7):1207-8. PubMed ID: 25967396
[No Abstract] [Full Text] [Related]
43. Exploration of the longitudinal trend of DUI crashes in Pennsylvania, USA (2008 to 2019).
Liu C
Traffic Inj Prev; 2021; 22(8):593-598. PubMed ID: 34570629
[TBL] [Abstract][Full Text] [Related]
44. Is law enforcement of drug-impaired driving cost-efficient? An explorative study of a methodology for cost-benefit analysis.
Veisten K; Houwing S; Mathijssen MP; Akhtar J
Int J Drug Policy; 2013 Mar; 24(2):122-34. PubMed ID: 23127668
[TBL] [Abstract][Full Text] [Related]
45. Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado.
Salomonsen-Sautel S; Min SJ; Sakai JT; Thurstone C; Hopfer C
Drug Alcohol Depend; 2014 Jul; 140():137-44. PubMed ID: 24831752
[TBL] [Abstract][Full Text] [Related]
46. User experience and operational feasibility of four point-of-collection oral fluid drug-testing devices according to Brazilian traffic agents.
Pechansky F; Scherer JN; Schuch JB; Roglio V; Telles YM; Silvestrin R; Pasa G; Sousa T
Traffic Inj Prev; 2019; 20(1):30-36. PubMed ID: 30822144
[TBL] [Abstract][Full Text] [Related]
47. Roadside opioid testing of drivers using oral fluid: the case of a country with a zero tolerance law, Spain.
Fierro I; Colás M; González-Luque JC; Álvarez FJ
Subst Abuse Treat Prev Policy; 2017 May; 12(1):22. PubMed ID: 28490343
[TBL] [Abstract][Full Text] [Related]
48. Roadside drug testing: An evaluation of the Alere DDS
Rohrig TP; Moore CM; Stephens K; Cooper K; Coulter C; Baird T; Garnier M; Miller S; Tuyay J; Osawa K; Chou J; Nuss C; Collier J; Wittman KC
Drug Test Anal; 2018 Apr; 10(4):663-670. PubMed ID: 28879663
[TBL] [Abstract][Full Text] [Related]
49. [Cannabis and automobile driving].
Ménétrey A; Augsburger M; Giroud C; Mangin P
Praxis (Bern 1994); 2001 Aug; 90(34):1398-407. PubMed ID: 11552320
[TBL] [Abstract][Full Text] [Related]
50. Driving Under the Influence of Drugs: When the Law Misses the Mark.
Tiscione NB; Alford IK; Miller R; Shan X; Yeatman DT
J Anal Toxicol; 2019 Mar; 43(2):138-143. PubMed ID: 30272174
[TBL] [Abstract][Full Text] [Related]
51. Road safety implications of the partial legalisation of cannabis in Germany: protocol for a quasi-experimental study.
Schranz A; Verthein U; Manthey J
BMJ Open; 2024 Jun; 14(6):e084611. PubMed ID: 38871660
[TBL] [Abstract][Full Text] [Related]
52. Correlation between oral fluid and blood THC concentration: A systematic review and discussion of policy implications.
Robertson MB; Li A; Yuan Y; Jiang A; Gjerde H; Staples JA; Brubacher JR
Accid Anal Prev; 2022 Aug; 173():106694. PubMed ID: 35640367
[TBL] [Abstract][Full Text] [Related]
53. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
Davey J; Leal N; Freeman J
Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
[TBL] [Abstract][Full Text] [Related]
54. Colorado drugged driving prevalence and impaired driving conviction rates: Effects of impaired driving definitions and a 5-nanogram limit for delta-9 tetrahydrocannabinol.
Wood EC
Traffic Inj Prev; 2024; 25(3):338-344. PubMed ID: 38175179
[No Abstract] [Full Text] [Related]
55. A comparison of alcohol and drug use by random motor vehicle drivers in Brazil and Norway.
Gjerde H; Sousa TR; De Boni R; Christophersen AS; Limberger RP; Zancanaro I; Oiestad EL; Normann PT; Mørland J; Pechansky F
Int J Drug Policy; 2014 May; 25(3):393-400. PubMed ID: 24613265
[TBL] [Abstract][Full Text] [Related]
56. Challenges associated with drunk driving measurement: combining police and self-reported data to estimate an accurate prevalence in Brazil.
Sousa T; Lunnen JC; Gonçalves V; Schmitz A; Pasa G; Bastos T; Sripad P; Chandran A; Pechansky F
Injury; 2013 Dec; 44 Suppl 4():S11-6. PubMed ID: 24377772
[TBL] [Abstract][Full Text] [Related]
57. The effects of medical marijuana laws on cannabis-involved driving.
Sevigny EL
Accid Anal Prev; 2018 Sep; 118():57-65. PubMed ID: 29885927
[TBL] [Abstract][Full Text] [Related]
58. Drugs in oral fluid in randomly selected drivers.
Drummer OH; Gerostamoulos D; Chu M; Swann P; Boorman M; Cairns I
Forensic Sci Int; 2007 Aug; 170(2-3):105-10. PubMed ID: 17658711
[TBL] [Abstract][Full Text] [Related]
59. The impact of marijuana decriminalization on California drivers.
Pollini RA; Romano E; Johnson MB; Lacey JH
Drug Alcohol Depend; 2015 May; 150():135-40. PubMed ID: 25765482
[TBL] [Abstract][Full Text] [Related]
60. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
Crouch DJ; Walsh JM; Cangianelli L; Quintela O
Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
